Search Results - "SZTURMOWICZ, M"

Refine Results
  1. 1

    Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab-Challenging Recognition and Treatment by Łyżwa, E, Sobiecka, M, Lewandowska, K, Siemion-Szcześniak, I, Barańska, I, Klatt, M, Langfort, R, Szturmowicz, M, Tomkowski, W

    Published in Viruses (01-03-2023)
    “…A Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) led to a pandemic outbreak in 2019. COVID-19's…”
    Get full text
    Journal Article
  2. 2

    CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients by Pujol, J-L, Molinier, O, Ebert, W, Daurès, J-P, Barlesi, F, Buccheri, G, Paesmans, M, Quoix, E, Moro-Sibilot, D, Szturmowicz, M, Bréchot, J-M, Muley, T, Grenier, J

    Published in British journal of cancer (01-06-2004)
    “…The purpose of this study was to determine the prognostic significance of a high pretreatment serum CYFRA 21-1 level (a cytokeratin 19 fragment) adjusted for…”
    Get full text
    Journal Article
  3. 3

    The value of the new scoring system for predicting neoplastic pericarditis in the patients with large pericardial effusion by Szturmowicz, M., Pawlak-Cieślik, A., Fijałkowska, A., Gątarek, J., Skoczylas, A., Dybowska, M., Błasińska-Przerwa, K., Langfort, R., Tomkowski, W.

    Published in Supportive care in cancer (01-08-2017)
    “…Purpose Early recognition of neoplastic pericarditis (npe) is crucial for the planning of subsequent therapy. The aim of the present study was to construct the…”
    Get full text
    Journal Article
  4. 4

    Neuroendocrine phenotype of non-small cell lung carcinoma : Immunohistological evaluation and biochemical study by SLODKOWSKA, J, ZYCH, J, SZTURMOWICZ, M, DEMKOW, U, ROWINSKA-ZAKRZEWSKA, E, ROSZKOWSKI-SLIZ, K

    “…The prevalence and distribution of neuroendocrine differentiation in non-small cell lung cancer (NSCLC) was estimated by assays for synaptophysin (SYN),…”
    Get full text
    Journal Article
  5. 5

    Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres by JØRGENSEN, L. G. M, ØSTERLIND, K, GENOLLA, J, GOMM, S. A, HERNANDEZ, J. R, JOHNSON, P. W. M, LØBER, J, SPLINTER, T. A. W, SZTURMOWICZ, M

    Published in British journal of cancer (01-08-1996)
    “…The influence of pretreatment serum neuron-specific enolase (S-NSE) in addition to more conventional prognostic factors on survival duration in small-cell lung…”
    Get full text
    Journal Article
  6. 6

    Frequency and clinical significance of beta-subunit human chorionic gonadotropin expression in non-small cell lung cancer patients by Szturmowicz, M, Slodkowska, J, Zych, J, Rudzinski, P, Sakowicz, A, Rowinska-Zakrzewska, E

    Published in Tumor biology (01-03-1999)
    “…Human chorionic gonadotropin (HCG), a classic trophoblastic marker, has been found recently in many nontrophoblastic tumors. Previously we have found elevated…”
    Get more information
    Journal Article
  7. 7

    Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis by Szturmowicz, M, Tomkowski, W, Fijalkowska, A, Kupis, W, Cieslik, A, Demkow, U, Langfort, R, Wiechecka, A, Orlowski, T, Torbicki, A

    “…A positive cytology result in pericardial fluid is the gold standard for recognition of malignant pericardial effusion. Unfortunately, in 30-50% of patients…”
    Get full text
    Journal Article
  8. 8

    Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis by SZTURMOWICZ, M, TOMKOWSKI, W, FIJALKOWSKA, A, KUPIS, W, CIESLIK, A, DEMKOW, U, LANGFORT, R, WIECHECKA, A, ORLOWSKI, T, TORBICKI, A

    “…A positive cytology result in pericardial fluid is the gold standard for recognition of malignant pericardial effusion. Unfortunately, in 30-50% of patients…”
    Get full text
    Journal Article
  9. 9

    Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels by Slodkowska, J, Szturmowicz, M, Rudzinski, P, Giedronowicz, D, Sakowicz, A, Androsiuk, W, Zakrzewska-Rowinska, E

    Published in European journal of cancer prevention (01-02-1998)
    “…The study of tumour markers in lung cancer has focused mainly on serum-based analysis. The controversy about carcinoembryonic antigen (CEA), pregnancy specific…”
    Get more information
    Journal Article
  10. 10

    Neuron-specific enolase in non-neoplastic lung diseases, a marker of hypoxemia? by Szturmowicz, M, Burakowski, J, Tomkowski, W, Sakowicz, A, Filipecki, S

    “…Neuron-specific enolase (NSE) is a glycolytic enzyme localized within neuronal and neuroendocrine tissues. Serum NSE is widely used as a marker of…”
    Get more information
    Journal Article
  11. 11

    The role of human chorionic gonadotropin β subunit elevation in small-cell lung cancer patients by SZTURMOWICZ, M, WIATR, E, SAKOWICZ, A, SLODKOWSKA, J, ROSZKOWSKI, K, FILIPECKI, S, ROWINSKA-ZAKRZEWSKA, E

    “…Human chorionic gonadotropin (HCG)-like immunoreactivity has been found in many non-trophoblastic tumours, but the biological behaviour of HCG-producing cells…”
    Get full text
    Journal Article
  12. 12

    Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion by TOMKOWSKI, W, SZTURMOWICZ, M, FIJALKOWSKA, A, FILIPECKI, S, FIGURA-CHOJAK, E

    “…Nine patients (seven men and two women), median age 57 years (range 40-68 years), with large malignant pericardial effusion confirmed by cytological…”
    Get full text
    Journal Article
  13. 13

    The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis by Szturmowicz, M, Tomkowski, W, Fijalkowska, A, Burakowski, J, Sakowicz, A, Filipecki, S

    “…This study was designed to assess the value of tumor marker evaluation in pericardial fluid for the recognition of malignant pericarditis. Thirty-six patients…”
    Get more information
    Journal Article
  14. 14

    The clinical value of Cyfra 21-1 estimation for lung cancer patients by Szturmowicz, M, Sakowicz, A, Rudzinski, P, Zych, J, Wiatr, E, Zaleska, J, Rowinska-Zakrzewska, E

    “…Cytokeratin-19, one of the cytoskeletal proteins, is expressed both in bronchial epithelium and in lung cancer cells. The aim of our study was to establish the…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade by Tomkowski, Witold Zbyszek, Wiśniewska, Joanna, Szturmowicz, Monika, Kuca, Paweł, Burakowski, Janusz, Kober, Jarosław, Fijałkowska, Anna

    Published in Supportive care in cancer (01-01-2004)
    “…To evaluate the effectiveness and side effects of intrapericardial administration of cisplatin in prevention of recurrent malignant pericardial effusion…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    1268 Is an increased carcinoembryonic antigen (CEA) concentration in pericardial fluid an indication of malignant pericarditis? by Szturmowicz, M., Tomkowski, W., Fijalkowska, A., Sakowicz, A., Filipecki, S.

    Published in European journal of cancer (1990) (01-11-1995)
    “…The aim of the study was to evaluate the role of CEA in pericardial fluid (pf) for the recognition of malignant pericarditis. 30 patients (pts): 15 men, 15…”
    Get full text
    Journal Article
  20. 20

    New approaches to the management and treatment of malignant pericardial effusion by TOMKOWSKI, W, SZTURMOWICZ, M, FIJAŁKOWSKA, A, BURAKOWSKI, J, FILIPECKI, S

    Published in Supportive care in cancer (1997)
    “…The purpose of this study was the evaluation of the effectiveness of intrapericardial administration of tetracycline, 5-fluorouracil and cisplatin in patients…”
    Get full text
    Journal Article